• Goldtrack Ventures launches a USD 250M industrial biotechnology growth fund in Saudi Arabia, targeting regional and international scaling opportunities.
• The fund will focus on biotech sectors including red, green, white, yellow, grey, blue, and golden, with industrial applications priority.
• Initial investments are expected in 2026, leveraging Goldtrack’s expertise, regional partnerships, and cross-sector collaboration to advance innovation ecosystems.

Goldtrack Ventures 

At the Global Health Exhibition (GHE) in Riyadh, Goldtrack Ventures launched its new USD 250 million industrial biotechnology growth fund in Saudi Arabia. 

The VC is structuring the fund and plans to file it with the Capital Market Authority (CMA) by late 2025. It expects to begin initial investments in 2026 to advance Saudi Arabia’s industrial biotechnology and innovation ecosystem.

The fund will focus on scaling biotechnology enterprises both locally and internationally. It aims to expand initially into Saudi Arabia and the wider MENA region. Additionally, it aims to catalyze collaborations that seek to translate scientific innovation into commercially scalable ventures.

Biotechnology

Its investment scope will include the red, green, white, yellow, grey, blue and golden sectors of biotechnology. This is with a focus on industrial applications, bio-based materials, agri-tech, and sustainable solutions aligned with national priorities.

“Along with the accelerating growth of digital ecosystems, we are building vibrant and industrial ecosystems – systems that will redefine how industries grow, produce, and sustainably thrive,” said Mark Rayner, Managing Partner at GOLDTRACK Ventures.

The VC’s team will leverage its expertise in international fund management, scientific research, and cross-sector collaboration. It will also leverage its regional network of academic and industrial partners. 

GOLDTRACK Ventures GmbH is a European-based investment and advisory firm focused on biotechnology and sustainable industrial innovation. Its team has a VC and entrepreneurial track record in connecting science, capital, and partnerships to scale businesses that redefine industries and create a more sustainable future.